ROP18 Mammalian Expression Vector Construction 1 1
Restriction digests of pGEX-6p-ROP 18 plasmid DNA were completed by using 1 2
BamHI-HF™ and NotI-HF™ (NEB), according to the product manuals. The ROP 18 1 3
DNA fragment was excised and ligated with the pcDNA5/FRT/TO by using T4 DNA 1 4
Ligase (NEB), according to the product manuals. Then the reaction mixture was 1 5
transformed into E. cloni® 10G competent cells. Individual colonies were picked and 1 6 the plasmid was extracted for screening the incorporation of the pcDNA5/FRT/TO: 1 7 ROP 18 DNA construct by restriction digestion with BamHI and NotI. The 1 8 appropriate plasmids were sent for DNA sequencing to confirm the integrity of the 1 9
plasmids. The sequencing primer is：5'-GACTTGCAGAGGGAGTCGTC -3'. 
4
The PCR amplification was performed according to manufacturer's instructions.
5
The PCR product was treated with 10 units of Dpn PBS and the coverslips were mounted on the glass slide with mounting solution.
0
For mitochondrial labeling, MitoTracker® dyes were diluted directly in the growth 2 1 medium at the concentration of 100nM and incubated for 30min at 37 °C. After 2 2 incubation, the cells were fixed in ice-cold methanol for 15 min at -20ºC then rinsed 3 2 3 times with PBS for 10 min each. Fluorescence reporter assay 2 6
The ATF6β-YFP/CFP reporter plasmids were transiently co-transfected with ROP18 Protein secretion analysis 1 7
The cell culture medium was collected and centrifuged at 13000xg for 5 min to 1 8
remove the cell debris. The medium was then concentrated by 30 kDa cutoff Amicon 1 9 concentrators, followed the manufacturer's instructions. The concentrated solutions 2 0
were analysed by western blotimmunoblotting with anti-β-Tubulin and anti-ROP18 2 1 antibodies respectively. Non-transfection and vector only were used as the controls.
2
The cell lysates from adherent culture cells were collected as transfection controls. 
8
The alignment results between predicted structure and x-ray 3D structure of kinase 9 domain are hereby listed (Table 1 ). The structural relatedness of the proteins involves 1 0 consideration of average root-mean-square deviation (RMSD), Q score (CαG 1 1 alignment) and % Sequence Identity.
1 2 1 3
The degree of superimposability could be extrapolated from RMSD. A low RMSD 1 4
between predicted structure of wild-type ROP18 and the known x-ray structure would 1 5
indicate a high degree of superimposability. However, a high RMSD was obtained 1 6
when comparing predicted structure of ROP18 kinase dead to predicted wild-type 1 7
ROP18 structure or the known x-ray structure, suggesting a big structural divergence 1 8 from both predicted wild-type ROP18 and known ROP18 crystal structure. There is a 61% sequence homology between the predicted kinase dead structure and 2 the x-ray 3D structure, where an 82% sequence identity between predicted wild-type 3 ROP18 models and the existing x-ray 3D structure.
5
The high degree of similarity between the wild-type ROP18 prediction, along with the 6 known x-ray 3D structure, indicated that I-TASSER prediction results were reliable. 1 5
with respect to either predicted wild-type ROP18 or existing x-ray structure at amino 1 6
acid residues V266 and D362 implies a significant disruption at ATP-binding sites.
1 7 1 8
Therefore, D409A mutation is hypothesized to cause conformational changes in 1 9
ROP18 not only on a local level but also on a global scale. 
3
Structural alignments shown were conducted using I-TASSER. RMSD (Root mean 2 4 square deviation) of aligned structures indicates their divergence from one another.
5
The Q-score takes into account the number of residues in corresponding secondary To characterize the role of the putative catalytic aspartate in the ROP18 protein kinase, 7 site-directed mutagenesis was employed to mutate the amino acid residue to alanine.
8
The necessity of the putative catalytic aspartate residue for kinase activity was 9 explored by comparing the activity of the wild-type ROP18 to that of the D409A 1 0 mutant. D409A mutation had similar expression level in bacteria to the wild-type 1 1 ROP18 ( Fig 1A) . Phosphorylation assays were carried out in the presence of ATP, 1 2
and reaction mixtures were analyzed by the ADP-Glo™ Kinase Assay Kit. In addition,
3
Western blots using anti-pThr antibody were used to examine the pThr status of the 1 4 1 5
proteins. ROP18 mutants showed a significant reduction in kinase activity, suggesting 1 an inability to be autophosphorylated at the key Thr residues ( Fig 1B) . It has been reported that ATF6β is a cellular host target of the T. gondii virulence 1 5 factor ROP18. ATF6β protein is consistently reduced in cells infected with parasites 1 6 harboring wild-type ROP18 but not with those lacking ROP18 (Δrop18 strain) [21].
7
To confirm these findings in ROP18-transfected mammalian cells, wild-type ROP18 1 8 or D409A mammalian expression vector was constructed. YFP-ATF6β fused to CFP, 1 9
with a self-cleavage signal [T2A] in between to produce the same level of both 2 0 proteins, was employed in an ROP18 co-transfection experiment. Protein level of 2 1
ATF6β was quantified and normalized against ratio of YFP to CFP. There was a 2 2 moderate reduction of ATF6β protein levels in cells co-transfected with ROP18 kinase 2 3 dead with respect to the vector control. Reduction in ATF6β protein levels was more 2 4 1 6 significant when cells were co-transfected with wild-type ROP18. Taken together, 1 these data suggest that kinase activity is involved in ROP18-mediated degradation 2 (Fig 2A) . In parallel, lysates of 293T cells co-transfected with ATF6β-HA and 3 wild-type ROP18 or ROP18 kinase dead were analyzed by immunoblotting.
4
ROP18-dependent decrease in ATF6β protein level was observed when 5 overexpressing wild-type ROP18 but such phenotype was not present in D409A 6 mutant. Expression of β -Tubulin was consistent across all samples, indicating that 7 general cellular homeostasis was unaffected by ROP18 transfection (Fig 2B) . 
3
To investigate the mechanisms of ROP18-mediated degradation, 293T cells with 2 4
overexpressed wild-type ROP18 and ATF6β-YFP were treated with MG132, which is 2 5 a cell-permeable proteasome inhibitor that has been reported to abrogate 2 6 1 7
ubiquitin-mediated proteasomal degradation. Untreated cells were used as a control.
1 Compared with the empty vector control and kinase dead, degradation could be 2 rescued in the presence of MG132, demonstrating that downregulation of ATF6β is 3 proteasome-dependent (Fig3A) . This result was further confirmed by 4 immunofluorescence, where there was a significant increase in ATF6β-YFP signal 5 intensity within ROP18-transfected cells after MG132 treatment in comparison to 6 transfected cells with dimethyl sulfoxide (DMSO) control ( Fig 3B) .
7
These data are consistent with the previous study, confirming that kinase activity is 8 involved in the ROP18-mediated degradation, and the degradation is in a 9 proteasome-dependent fashion. 
5
To assess whether overexpressed ATF6β is translocated into Golgi apparatus, 293T 1 6 cells co-transfected with pcDNA vector control or ATF6β-YFP for 48 hours were 1 7
fixed for immunostaining with anti-giantin antibody, which is a known Golgi marker.
8
ATF6β-YFP protein co-localized with giantin, thereby suggesting that ATF6β 1 9
associates with the Golgi (Fig 5, upper panel 
3
In both conditions, ROP18 was mainly distributed in the Golgi apparatus, where it 4 colocalised with ATF6β-YFP (Fig 5, lower panel) .
6
Altogether these results suggest that T. gondii ROP18 protein physically interacts with 7 ATF6β in transfected human cells and that such interaction occurs in the Golgi 8 apparatus. 4 was not only found inside Golgi compartments and on cell surface but also observable 5 in small cytosolic patches, which could be intracellular trafficking vesicles (Fig 6) .
An inability of those cytosolic patches to colocalize with mitochondrial, transfected with wild-type ROP18 or ROP18 kinase dead plasmid for 24hr and 48 hr.
3
Cells were fixed, permeabilized or not with Triton X-100 and stained with rabbit 1 4
anti-ROP pAb and followed by Alexa Fluor® 568 goat anti-rabbit secondary antibody.
5
Images were captured with a Zeiss fluorescence microscope using 63x objectives.
